Merck is preparing for a potential U.S. launch of an oncology mRNA-based, individualized neoantigen therapy for early stage melanoma and is building a field-based team to educate treatment sites on workflows, tools, and operational requirements to onboard the product and sustain end-to-end execution from onboarding through steady-state operations.
The Associate Director Oncology Treatment Site Lead will be the primary field contact for sites, coordinating with cross-functional partners,
#J-18808-LjbffrAssociate Director, Oncology Site Operations & Readiness in columbia at Unknown Company
This position is listed as full time and onsite.